Delivery Order SPE2DR25D1100-SPE2DR26FCM4J
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,214.08 for Infuvite Adult 10ML (5 units) by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract employs firm fixed-price pricing and was competitively awarded with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,944.39 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Infuvite Adult Vial 10ML, a parenteral nutrition product used in medical settings. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $11,542.88 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Infuvite Adult Vial 10ML, a parenteral nutrition product. The contract is firm fixed price with no set-aside designation, reflecting competitive procurement practices. Performance is scheduled for completion by November 7, 2025, with work to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a $4,999.10 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $6,378.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Infuvite Adult Vial 10ML, a parenteral nutrition product. This non-set-aside, firm fixed-price contract is scheduled for completion by June 2, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at approximately $61,000 to AmerisourceBergen Drug Corp for Infuvite Adult Bulk Vial 100ML, a parenteral nutrition product. This competitive, firm fixed-price delivery order was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will perform...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Infuvite Adult Vial 10ML, a pharmaceutical product used in clinical nutrition support. This firm fixed price delivery order has a ceiling value of $3,008.21 and is scheduled for completion by August 5, 2025. The award was competitively procured with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $11,265.34 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product used in clinical settings. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery...
- The Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,793.37 for INFUVITE Adult Vial 10ML, a parenteral nutrition product used in clinical settings. This firm fixed-price delivery order, issued on August 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a $1,499.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Infuvite Adult Vial 10ML, an intravenous nutritional supplement used in medical and military healthcare settings. This non-set-aside competitive award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCM4JDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,535.79 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Infuvite Adult Vial 10ml, a nutritional support product. This non-set-aside, firm fixed-price delivery order represents a competitive award and is scheduled for completion by November 5, 2025. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and extending through December 2026. This comprehensive contract vehicle enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for Defense Health Agency, military, and veteran healthcare systems. The company's portfolio of DLA delivery orders demonstrates its capability to fulfill diverse medical supply requirements through open competition, encompassing specialty medications, generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains. This delivery order for Infuvite Adult Vial reflects the company's ongoing role as a primary supplier within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 11/4/25 |